Specialty Pharmaceuticals Service Summary
Research Overview
The Specialty Pharmaceuticals Service provides market research in benefit plan design and utilization management for specialty medications. Annual research provides detailed data on U.S. health plans management of specialty pharmaceuticals in their commercial business and the implications of the underlying coverage trends. Fixed and percent copay enrollments, copay pricing, specialty pharmacy provider usage, physician reimbursement and key utilization management tactics are highlighted. Eight key injectable categories are profiled in detail including:
- Asthma
- Erythropoiesis-Stimulating Agents (ESAs)
- Hepatitis C
- Multiple Sclerosis
- Osteoporosis
- Psoriasis
- Rheumatoid Arthritis
- White Blood Cell Stimulants
Who Should Subscribe?
Business development executives and strategic planners for specialty medication products will find the insightful implications and trend information useful for developing contracting and marketing strategies. Market research, product management and account executives will find the trends, practices, data and information useful for planning and assessing specific brand and customer strategies and tactics.
Why Subscribe?
HIRC research benefits manufacturers of specialty medications who are seeking knowledge of health plan enrollment, pricing, and utilization management trends and strive to effectively:
- anticipate strategic opportunities and threats;
- develop effective programs;
- efficiently allocate resources, and
- design product launch and pull-through initiatives.